Table 2.
Subgroup | Year | P-value | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | ||
Candidemia (%) | 15.23 | 15.86 | 14.11 | 12.47 | 13.78 | 13.94 | 15.19 | 15.41 | 15.52 | 16.3 | 16.2 | 16.56 | <0.05a |
CLABSI, yes (%) | 93.24 | 92.79 | 93.23 | 94.08 | 88.96 | 93 | 94.86 | 94.97 | 92.41 | 91.78 | 91.33 | 91.44 | 0.17a |
Candida species (%) | 0.29b | ||||||||||||
C. albicans | 31.08 | 32.43 | 36.09 | 38.16 | 39.26 | 42.5 | 38.79 | 39.20 | 34.18 | 38.36 | 40.87 | 40.37 | |
Non-albicans spp. | 66.22 | 66.67 | 63.91 | 55.92 | 56.44 | 52 | 57.48 | 55.28 | 62.66 | 57.53 | 56.35 | 58.02 | |
Non-Candida fungi (%) | 2.7 | 0.9 | 0 | 5.92 | 4.29 | 5.5 | 3.74 | 5.53 | 3.16 | 4.11 | 2.79 | 1.6 | |
Size of hospitals (%) | <0.05b | ||||||||||||
300–699 beds | 2.7 | 0.9 | 5.26 | 1.97 | 4.91 | 2.5 | 5.14 | 8.04 | 6.96 | 6.39 | 11.76 | 13.64 | |
700–899 beds | 51.35 | 48.65 | 60.15 | 48.68 | 47.85 | 58.5 | 61.68 | 53.77 | 48.1 | 58.45 | 56.97 | 58.02 | |
≥900 beds | 45.95 | 50.45 | 34.59 | 49.34 | 47.24 | 39 | 33.18 | 38.19 | 44.94 | 35.16 | 31.27 | 28.34 | |
Type of ICU (%) | <0.05b | ||||||||||||
Medical ICU | 83.78 | 83.79 | 78.19 | 77.63 | 81.59 | 75.5 | 67.76 | 72.86 | 68.98 | 71.24 | 76.16 | 78.34 | |
Surgical ICU | 16.22 | 16.22 | 21.8 | 22.37 | 18.4 | 24.5 | 32.24 | 27.14 | 31.01 | 28.77 | 23.84 | 21.66 | |
Organ transplant wards, yes (%) | 18.92 | 31.53 | 33.83 | 32.89 | 29.45 | 35.00 | 27.57 | 30.15 | 31.65 | 25.57 | 21.98 | 21.12 | <0.05a |
The P-value was obtained using the one-sided aCochran-Armitage trend test or bthe one-sided Cochran-Mantel-Haenszel mean score test.
CLABSI, central line-associated bloodstream infection; ICU, intensive care unit.